Clinical Trials Directory

Trials / Unknown

UnknownNCT01811394

Ion Irradiation of Sacrococcygeal Chordoma

Hypofractionated Ion Irradiation (Protons or Carbon Ions) of Sacrococcygeal Chordoma

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Heidelberg University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and feasibility of primary hypofractionated irradiation of sacrococcygeal chordoma with carbon ions or protons using the raster scan technique.

Detailed description

The primary objective of this trial is safety and feasibility of hypofractionated irradiation in patients with sacrococcygeal chordoma using protons or carbon ions in raster scan technique for primary or additive treatment after R2 resection. The evaluation is therefore based on the proportion of treatments without Grade 3-5 toxicity (CTCAE, version 4.0) up to 12 months after treatment and/or discontinuation of the treatment for any reason as primary endpoint. Local-progression free survival, overall survival and quality of life will be analyzed as secondary end points.

Conditions

Interventions

TypeNameDescription
RADIATIONprotonsTreatment is performed using 16 x 4 GyE protons
RADIATIONcarbon ionsTreatment is performed using 16 x 4 GyE carbon ions

Timeline

Start date
2013-01-01
Primary completion
2023-02-01
Completion
2025-06-01
First posted
2013-03-14
Last updated
2023-12-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01811394. Inclusion in this directory is not an endorsement.